From January through March, 2021, Rutstein worked closely with scientists at Integral Molecular, a biotech company at the UC Science Center in Philadelphia, who have developed innovative technology to simulate how living cells get infected by SARS-Cov-2 variants in order to further antibody research for vaccines. During her residency period she created small paintings in response to her observations in the lab, and is currently working on a larger body of paintings and a sculptural installation incorporating light and sound for a solo exhibition at the Esther Klein Gallery in August 2021.

The Science Center and Integral Molecular launched the BioArt Residency as an unparalleled artist-in-residence experience, enabling artists to immerse themselves in a laboratory environment and explore the complexities of scientific research. The artists’ creative interpretations serve to engage broader audiences and stimulate meaningful dialogue and awareness. The BioArt Residency serves to improve the understanding of science and technology, foster a creative dialogue between artists and scientists, and create a direct positive impact on human health.